|
n |
% |
|
n |
% |
|
n |
% |
Diagnosis |
|
|
|
|
|
|
|
|
Imaging techniques:
|
|
|
|
|
|
|
|
|
No exams
|
7
|
16.3
|
|
7
|
46.7
|
|
0
|
0.0
|
Chest X-ray
|
20
|
46.5
|
|
5
|
33.3
|
|
14
|
51.9
|
Chest TC
|
3
|
7.0
|
|
0
|
0.0
|
|
3
|
11.1
|
Lung ultrasound
|
4
|
9.3
|
|
0
|
0.0
|
|
4
|
14.8
|
Chest X-ray + Lung ultrasound
|
8
|
18.6
|
|
2
|
13.3
|
|
6
|
22.2
|
Chest X-ray + Chest TC
|
1
|
2.3
|
|
1
|
6.7
|
|
0
|
0.0
|
Vital signs and laboratory reports |
|
|
|
|
|
|
|
|
Body temperature > 37.5 °C
|
15
|
34.9
|
|
4
|
26.7
|
|
11
|
40.7
|
Lymphopenia (<1500 mm3)
|
22
|
51.2
|
|
5
|
33.3
|
|
17
|
63.0
|
CRP values >10mg/100ml
|
13
|
30.2
|
|
1
|
6.7
|
|
12
|
44.4
|
Oxygen saturation <95%
|
8
|
18.6
|
|
1
|
6.7
|
|
7
|
25.9
|
Blood gas test
|
|
|
|
|
|
|
|
|
Not performed
|
13
|
30.2
|
|
8
|
53.3
|
|
4
|
14.8
|
Performed, normal result
|
14
|
32.6
|
|
6
|
40.0
|
|
8
|
29.6
|
Performed, pathological result
|
16
|
37.2
|
|
1
|
6.7
|
|
15
|
55.6
|
Drug therapy |
|
|
|
|
|
|
|
|
Antiviral drugs:
|
22
|
51.2
|
|
4
|
26.7
|
|
17
|
63.0
|
Lopinavir
|
15
|
34.9
|
|
3
|
20.0
|
|
11
|
40.7
|
Darunavir
|
6
|
14.0
|
|
1
|
6.7
|
|
5
|
18.5
|
Norvir, Tolicizumab, Remdesivir
|
3
|
7.0
|
|
0
|
0.0
|
|
3
|
11.1
|
Hydroxicloroquine
|
22
|
51.2
|
|
3
|
20.0
|
|
18
|
66.7
|
Empirical antibiotic therapy
|
20
|
46.5
|
|
4
|
26.7
|
|
16
|
59.3
|
Targeted antibiotic therapy
|
4
|
9.3
|
|
2
|
13.3
|
|
2
|
7.4
|
Antenatal coricosteroids for fetal lung maturation
|
5
|
11.6
|
|
2
|
13.3
|
|
3
|
11.1
|
Critical care |
|
|
|
|
|
|
|
|
Non invasive respiratory support
|
19
|
44.2
|
|
2
|
13.3
|
|
17
|
63.0
|
Invasive respiratory support
|
8
|
18.6
|
|
0
|
0.0
|
|
8
|
29.6
|
Orotracheal intubation
|
1
|
2.3
|
|
0
|
0.0
|
|
1
|
3.7
|
Admission to sub-intensive care unit
|
1
|
2.3
|
|
0
|
0.0
|
|
1
|
3.7
|
Admission to intensive care unit
|
3
|
7.0
|
|
0
|
0.0
|
|
3
|
11.1
|
Extracorporeal membrane oxygenation
|
0
|
0.0
|
|
0
|
0.0
|
|
0
|
0.0
|